{"transactions":[{"id":931973,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-23T20:07:30.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting with 1/48th vesting on the date of grant and the remaining options vesting on the 1st day of each subsequent month, such that the total number of shares shall be fully vested on December 1, 2029."}],"balance_after":200000,"derivative":{"exercise_price":3.08,"expiration_date":"2036-01-23","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000912282-26-000120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000091228226000120/form4.xml","form_type":"4"}},{"id":1103453,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"officer":true,"officer_title":"President"}}],"security":"Warrants","published_at":"2025-06-23T08:46:04.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":7548,"price":0.125,"value":943.5,"ownership":{"direct":true},"balance_after":7548,"derivative":{"exercise_price":1.2,"exercise_date":"2025-06-18","expiration_date":"2030-06-18","underlying":"Common Shares","underlying_shares":7548},"source":{"system":"sec-edgar","filing":"0000912282-25-000696","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000091228225000696/form4.xml","form_type":"4"}},{"id":1103452,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Shares","published_at":"2025-06-23T08:46:04.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":7548,"price":1.2,"value":9057.6,"ownership":{"direct":true},"balance_after":130009,"source":{"system":"sec-edgar","filing":"0000912282-25-000696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000091228225000696/form4.xml","form_type":"4"}},{"id":1273471,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-11T17:43:17.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2025, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":300000,"derivative":{"exercise_price":1.6,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001415889-25-003615","document":"form4-02112025_100214.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000141588925003615/form4-02112025_100214.xml","form_type":"4"}},{"id":1424975,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT"}}],"security":"Common Stock","published_at":"2024-08-22T17:51:16.000Z","date":"2024-08-20","kind":"purchase","planned":false,"acquired":true,"shares":48387,"price":0.65,"value":31451.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $0.62 to $0.66, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":122461,"source":{"system":"sec-edgar","filing":"0001415889-24-022054","document":"form4-08222024_090813.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000141588924022054/form4-08222024_090813.xml","form_type":"4"}},{"id":1660706,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-02T18:02:04.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2024, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date."}],"balance_after":145000,"derivative":{"exercise_price":1.31,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001415889-24-002380","document":"form4-02022024_110255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000141588924002380/form4-02022024_110255.xml","form_type":"4"}},{"id":1786661,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-06T17:43:20.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":545000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option will vest one year after the date of the grant of September 1, 2023 and the remaining shares will vest in equal monthly installments over the following three years thereafter."}],"balance_after":545000,"derivative":{"exercise_price":1.3,"expiration_date":"2033-08-31","underlying":"Common Stock","underlying_shares":545000},"source":{"system":"sec-edgar","filing":"0001209191-23-048483","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1624830/000120919123048483/doc4.xml","form_type":"4"}},{"id":2957791,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:23.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-132153","document":"tm2037705d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132153/tm2037705d6_4.xml","form_type":"4"}},{"id":2957790,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:23.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":130680,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.7825,"underlying":"Common Stock","underlying_shares":130680},"source":{"system":"sec-edgar","filing":"0001104659-20-132153","document":"tm2037705d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132153/tm2037705d6_4.xml","form_type":"4"}},{"id":2957789,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:23.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-20-132153","document":"tm2037705d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132153/tm2037705d6_4.xml","form_type":"4"}},{"id":2957788,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:23.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":79097,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":4.37,"underlying":"Common Stock","underlying_shares":79097},"source":{"system":"sec-edgar","filing":"0001104659-20-132153","document":"tm2037705d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132153/tm2037705d6_4.xml","form_type":"4"}},{"id":2957787,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-03T21:41:23.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":157918,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the stock options were disposed of as follows: the reporting person received an option to purchase one (1) share of Petros Common Stock for every option to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":7.55,"underlying":"Common Stock","underlying_shares":157918},"source":{"system":"sec-edgar","filing":"0001104659-20-132153","document":"tm2037705d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920132153/tm2037705d6_4.xml","form_type":"4"}},{"id":2965081,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T17:09:21.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros (together, the \"Mergers\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In the event the reporting person departs from the board of directors following the consummation of the Mergers, the options shall expire on the date that is one year from the date of the consummation of the Mergers."}],"balance_after":40000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-130079","document":"tm2037145d6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465920130079/tm2037145d6_4seq1.xml","form_type":"4"}},{"id":3340599,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-12-16T17:00:22.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":130680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest in equal daily installments over a two-year period beginning on the date of grant."}],"balance_after":130680,"derivative":{"exercise_price":0.7825,"expiration_date":"2029-12-13","underlying":"Common Stock","underlying_shares":130680},"source":{"system":"sec-edgar","filing":"0001104659-19-073078","document":"tm1925244-1_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000110465919073078/tm1925244-1_form4.xml","form_type":"4"}},{"id":3517706,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-21T20:09:49.000Z","date":"2019-05-17","kind":"grant","acquired":true,"shares":175435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date."}],"balance_after":175435,"derivative":{"exercise_price":0.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":175435},"source":{"system":"sec-edgar","filing":"0001144204-19-027507","document":"tv522085_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744452/000114420419027507/tv522085_4.xml","form_type":"4"}},{"id":3579457,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020."}],"balance_after":75000,"derivative":{"exercise_price":0.75,"expiration_date":"2028-10-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579456,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020."}],"balance_after":0,"derivative":{"exercise_price":1.23,"expiration_date":"2028-10-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579455,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.75,"expiration_date":"2027-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579454,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2027-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579453,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":46000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable to the extent of 15,334 shares on June 10, 2016 and 15,333 shares on each of June 10, 2017 and June 10, 2018."}],"balance_after":46000,"derivative":{"exercise_price":0.75,"expiration_date":"2026-06-10","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579452,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":46000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable to the extent of 15,334 shares on June 10, 2016 and 15,333 shares on each of June 10, 2017 and June 10, 2018."}],"balance_after":0,"derivative":{"exercise_price":3.73,"expiration_date":"2026-06-10","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579451,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable to the extent of 10,000 shares on December 22, 2015, 3,334 shares on September 4, 2016, and 3,333 shares on each of September 4, 2017 and September 4, 2018."}],"balance_after":20000,"derivative":{"exercise_price":0.75,"expiration_date":"2025-09-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579450,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable to the extent of 10,000 shares on December 22, 2015, 3,334 shares on September 4, 2016, and 3,333 shares on each of September 4, 2017 and September 4, 2018."}],"balance_after":0,"derivative":{"exercise_price":4.7,"expiration_date":"2025-09-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579449,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 5,000 shares on each of April 6, 2016, April 6, 2017 and April 6, 2018."}],"balance_after":15000,"derivative":{"exercise_price":0.75,"expiration_date":"2025-04-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3579448,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-03-25T23:33:04.000Z","date":"2019-03-25","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 5,000 shares on each of April 6, 2016, April 6, 2017 and April 6, 2018."}],"balance_after":0,"derivative":{"exercise_price":4.7,"expiration_date":"2025-04-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-19-007601","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761919007601/doc1.xml","form_type":"4"}},{"id":3687788,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T18:01:17.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was made pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan. The stock options shall vest according to the following schedule: 50% vest on the date of grant, with the remaining stock options vesting in equal quarterly installments over a two-year period following the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":3.93,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001144204-19-002682","document":"v511522_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420419002682/v511522_4.xml","form_type":"4"}},{"id":3728828,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-17T17:01:30.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":79097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest in equal daily installments over a three-year period beginning on the date of grant."}],"balance_after":79097,"derivative":{"exercise_price":4.37,"expiration_date":"2028-12-14","underlying":"Common Stock","underlying_shares":79097},"source":{"system":"sec-edgar","filing":"0001144204-18-064951","document":"tv509225_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420418064951/tv509225_4.xml","form_type":"4"}},{"id":3778881,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-10-31T20:02:01.000Z","date":"2018-10-29","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020."}],"balance_after":75000,"derivative":{"exercise_price":1.23,"expiration_date":"2028-10-29","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001567619-18-004863","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761918004863/doc1.xml","form_type":"4"}},{"id":3789555,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-17T18:15:47.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":12778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant."}],"balance_after":12778,"derivative":{"exercise_price":5.82,"expiration_date":"2023-10-17","underlying":"Common Stock","underlying_shares":12778},"source":{"system":"sec-edgar","filing":"0001144204-18-054172","document":"tv504852_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744452/000114420418054172/tv504852_4.xml","form_type":"4"}},{"id":3789554,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-10-17T18:15:47.000Z","date":"2018-10-17","kind":"disposition_to_issuer","acquired":false,"shares":12778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from October 17, 2018 to October 17, 2023, resulting in the deemed cancelation of the \"old\" option and the grant of a replacement option. The option was originally granted on October 17, 2013 and provided for immediate vesting upon date of grant."}],"balance_after":0,"derivative":{"exercise_price":5.82,"expiration_date":"2018-10-17","underlying":"Common Stock","underlying_shares":12778},"source":{"system":"sec-edgar","filing":"0001144204-18-054172","document":"tv504852_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744452/000114420418054172/tv504852_4.xml","form_type":"4"}},{"id":3991096,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-19T20:05:16.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":7204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest immediately upon date of grant."}],"balance_after":7204,"derivative":{"exercise_price":1.57,"expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":7204},"source":{"system":"sec-edgar","filing":"0001144204-18-015576","document":"tv488775_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744452/000114420418015576/tv488775_form4.xml","form_type":"4"}},{"id":3991095,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-19T20:05:16.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":63919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date."}],"balance_after":63919,"derivative":{"exercise_price":1.57,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":63919},"source":{"system":"sec-edgar","filing":"0001144204-18-015576","document":"tv488775_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744452/000114420418015576/tv488775_form4.xml","form_type":"4"}},{"id":4128295,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-18T17:34:56.000Z","date":"2017-12-14","kind":"grant","acquired":true,"shares":157918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued in connection with the Reporting Person's appointment as a director to the Issuer's board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Half of the stock options shall vest upon grant, and the remaining stock options shall vest daily over the following four-year period."}],"balance_after":157918,"derivative":{"exercise_price":7.55,"expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":157918},"source":{"system":"sec-edgar","filing":"0001144204-17-064174","document":"tv481442_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1513856/000114420417064174/tv481442_form4.xml","form_type":"4"}},{"id":4270774,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-29T23:04:59.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":14205,"price":1.76,"value":25000.8,"ownership":{"direct":true},"balance_after":14205,"source":{"system":"sec-edgar","filing":"0001571049-17-006372","document":"t1700414e-ryan0628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744452/000157104917006372/t1700414e-ryan0628.xml","form_type":"4"}},{"id":4272415,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-06-26T21:06:05.000Z","date":"2017-06-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is exercisable to the extent of 33,334 shares on June 23, 2017, and 33,333 shares on each of June 23, 2018 and June 23, 2019."}],"balance_after":100000,"derivative":{"exercise_price":3.35,"expiration_date":"2027-06-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-17-026108","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117026108/doc1.xml","form_type":"4"}},{"id":4402646,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2017-03-03T17:24:14.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":26667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for accrued director fees."}],"balance_after":26667,"derivative":{"exercise_price":4,"exercise_date":"2017-03-01","expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001140361-17-010429","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117010429/doc1.xml","form_type":"4"}},{"id":4402645,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-03T17:24:14.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":26667,"price":3,"value":80001.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In exchange for accrued director fees."}],"balance_after":42917,"source":{"system":"sec-edgar","filing":"0001140361-17-010429","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117010429/doc1.xml","form_type":"4"}},{"id":4442031,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2017-02-16T18:58:27.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable to the extent of 10,000 shares on December 22, 2015, 3,334 shares on September 4, 2016, and 3,333 shares on each of September 4, 2017 and September 4, 2018."}],"balance_after":20000,"derivative":{"exercise_price":4.7,"expiration_date":"2025-09-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-007883","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117007883/doc1.xml","form_type":"4"}},{"id":4442030,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2017-02-16T18:58:27.000Z","date":"2017-02-14","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is exercisable to the extent of 10,000 shares on December 22, 2015, 3,334 shares on September 4, 2016, and 3,333 shares on each of September 4, 2017 and September 4, 2018."}],"balance_after":0,"derivative":{"exercise_price":7,"expiration_date":"2025-09-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-007883","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117007883/doc1.xml","form_type":"4"}},{"id":4442029,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2017-02-16T18:58:27.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 5,000 shares on each of April 6, 2016, April 6, 2017 and April 6, 2018."}],"balance_after":15000,"derivative":{"exercise_price":4.7,"expiration_date":"2025-04-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-007883","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117007883/doc1.xml","form_type":"4"}},{"id":4442028,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2017-02-16T18:58:27.000Z","date":"2017-02-14","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option at a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests to the extent of 5,000 shares on each of April 6, 2016, April 6, 2017 and April 6, 2018."}],"balance_after":0,"derivative":{"exercise_price":8,"expiration_date":"2025-04-06","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-007883","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000114036117007883/doc1.xml","form_type":"4"}},{"id":4513875,"issuer":{"id":8621,"kind":"organization","name":"BNB PLUS CORP.","symbol":"BNBX"},"owners":[{"id":68487,"kind":"person","name":"Ryan Charles S.","position":1,"cik":"0001624830","reported_name":"Ryan Charles S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-12-22T21:07:53.000Z","date":"2016-12-20","kind":"grant","acquired":true,"shares":44787,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest in full and become exercisable on the first anniversary of the date of grant, subject to continued board membership through such date."}],"balance_after":44787,"derivative":{"exercise_price":2.05,"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":44787},"source":{"system":"sec-edgar","filing":"0001571049-16-020816","document":"t1600811e-ryan1220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744452/000157104916020816/t1600811e-ryan1220.xml","form_type":"4"}}]}